Abstract
Clinical OMICsVol. 2, No. 5 SNAPSHOTLDT Labs Prepare for the Eventuality of FDA OversightNina Peled and Plamena Entcheva-DimitrovNina PeledNINA PELED, Ph.D., and PLAMENA ENTCHEVA-DIMITROV, Ph.D., are the principals at IVD/LDT Expert Regulatory Consultants. (E-mail Address: npeled@yahoo.com / www.ivdadvisors.com)Search for more papers by this author and Plamena Entcheva-DimitrovNINA PELED, Ph.D., and PLAMENA ENTCHEVA-DIMITROV, Ph.D., are the principals at IVD/LDT Expert Regulatory Consultants. (E-mail Address: npeled@yahoo.com / www.ivdadvisors.com)Search for more papers by this authorPublished Online:3 Oct 2015https://doi.org/10.1089/clinomi.02.05.08AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 2Issue 5May 2015 InformationCopyright © GEN PublishingTo cite this article:Nina Peled and Plamena Entcheva-Dimitrov.LDT Labs Prepare for the Eventuality of FDA Oversight.Clinical OMICs.May 2015.20-21.http://doi.org/10.1089/clinomi.02.05.08Published in Volume: 2 Issue 5: October 3, 2015PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
